SEARCH

SEARCH BY CITATION

References

  • 1
    MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia. 1995;38:610616.
  • 2
    Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ. 1996;313:779784.
  • 3
    Ljungman S, Wikstrand J, Hartford M, et al. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged non-diabetic normal and hypertensive men. Am J Hypertens. 1996;9:770778.
  • 4
    Donnelly R, Yeung JM, Manning G. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. J Hypertens Suppl. 2003;21(suppl 1):S7S12.
  • 5
    Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421426.
  • 6
    Wachtell K, Ibsen H, Olsen MH, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901906.
  • 7
    Spoelstra-de Man AM, Brouwer CB, Stehouwer CD, et al. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2001;24:20972101.
  • 8
    Shahinfar S, Dickson TZ, Ahmed T, et al. Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study. Kidney Int Suppl. 2002;82:6467.
  • 9
    Fabre J, Balant LP, Dayer PG, et al. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int. 1982;21:730738.
  • 10
    Klein R, Klein BE, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care. 1993;16:13251330.
  • 11
    Olivarius Nde F, Andreasen AH, Keiding N, et al. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes Care in General Practice,” Denmark. Diabetologia. 1993;36:10071016.
  • 12
    Fillenbaum GG, Pieper CF, Cohen HJ, et al. Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol A Biol Sci Med Sci. 2000;55:M84M89.
  • 13
    Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105111.
  • 14
    Lee CD, Folsom AR, Pankow JS, et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855860.
  • 15
    Nielsen S, Schmitz A, Poulsen PL, et al. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Diabetes Care. 1995;18:14341441.
  • 16
    Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes. 1994;43:12481253.
  • 17
    Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797805.
  • 18
    Palmas W, Moran A, Pickering T, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension. 2006;48:301308.
  • 19
    Palmas W, Pickering T, Eimicke J, et al. Value of ambulatory arterial stiffness index and 24-hour pulse pressure to predict progression of albuminuria in elderly people with diabetes mellitus. Am J Hypertens. 2007;20:493500.
  • 20
    Staessen JA, Thijs L, O'Brien ET, et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens. 2002;15:835843.
  • 21
    Shea S, Starren J, Weinstock RS, et al. Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design. J Am Med Inform Assoc. 2002;9:4962.
  • 22
    K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1S266.
  • 23
    Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871881.
  • 24
    Pickering TG. Ambulatory Blood Pressure. Redmond, WA: Spacelabs Medical; 1994.
  • 25
    Llabre MM, Ironson GH, Spitzer SB, et al. How many blood pressure measurements are enough? An application of generalizability theory to the study of blood pressure reliability. Psychophysiology. 1988;25:97106.
  • 26
    Di Iorio A, Marini E, Lupinetti M, et al. Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing. 1999;28:2328.
  • 27
    Roman MJ, Pickering TG, Schwartz JE, et al. Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? J Hypertens. 1997;15:969978.
  • 28
    Kleinbaum DG, Klein M. Survival Analysis. 2nd ed. New York, NY: Springer; 2005.
  • 29
    Hedblad B, Ogren M, Engstrom G, et al. Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis. 2005;179:177183.
  • 30
    Streiner DL. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry. 2002;47:262266.
  • 31
    MacCallum RC, Zhang S, Preacher KJ, et al. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002;7:1940.
  • 32
    Khattar RS, Swales JD, Banfield A, et al. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100:10711076.
  • 33
    Nakano S, Ito T, Furuya K, et al. Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects. Hypertens Res. 2004;27:647656.
  • 34
    Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 2005;22:755776.
  • 35
    Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the HALT study. Hypertension. 2000;35:787794.
  • 36
    Qiu YG, Zhu JH, Tao QM, et al. Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. Cardiovasc Drugs Ther. 2005;19:189195.
  • 37
    White WB, Mehrotra DV, Black HR, et al. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group. Am J Cardiol. 1997;80:469474.
  • 38
    Uzu T, Harada T, Namba T, et al. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators. J Hypertens. 2005;23:861865.
  • 39
    Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100:16351638.
  • 40
    Psaty BM, Koepsell TD, Lin D, et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc. 1999;47:749754.
  • 41
    Nelson RG, Knowler WC, Pettitt DJ, et al. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med. 1991;151:17611765.
  • 42
    Gatling W, Knight C, Mullee MA, et al. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med. 1988;5:343347.
  • 43
    Hutchison AS, O'Reilly DS, MacCuish AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem. 1988;34:20192021.
  • 44
    Chaiken RL, Khawaja R, Bard M, et al. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care. 1997;20:709713.
  • 45
    Pang TC, Brown MA. Accuracy of ambulatory blood pressure monitors in routine clinical practice. Am J Hypertens. 2006;19:801809.